Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1986 1
1988 3
1990 1
1991 1
1992 2
1994 1
1995 4
1996 1
1997 1
1998 5
1999 3
2000 6
2001 4
2002 4
2003 4
2004 4
2005 2
2006 3
2007 4
2008 11
2009 4
2010 4
2011 5
2012 2
2013 7
2014 4
2015 8
2016 3
2017 2
2018 6
2019 2
2020 3
2021 4
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Rummel MJ, et al. Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20. Lancet. 2013. PMID: 23433739 Clinical Trial.
Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
Al-Batran SE, Hartmann JT, Probst S, Schmalenberg H, Hollerbach S, Hofheinz R, Rethwisch V, Seipelt G, Homann N, Wilhelm G, Schuch G, Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, Jäger E; Arbeitsgemeinschaft Internistische Onkologie. Al-Batran SE, et al. J Clin Oncol. 2008 Mar 20;26(9):1435-42. doi: 10.1200/JCO.2007.13.9378. J Clin Oncol. 2008. PMID: 18349393 Clinical Trial.
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Kunzmann V, Siveke JT, Algül H, Goekkurt E, Siegler G, Martens U, Waldschmidt D, Pelzer U, Fuchs M, Kullmann F, Boeck S, Ettrich TJ, Held S, Keller R, Klein I, Germer CT, Stein H, Friess H, Bahra M, Jakobs R, Hartlapp I, Heinemann V; German Pancreatic Cancer Working Group (AIO-PAK) and NEOLAP investigators. Kunzmann V, et al. Lancet Gastroenterol Hepatol. 2021 Feb;6(2):128-138. doi: 10.1016/S2468-1253(20)30330-7. Epub 2020 Dec 16. Lancet Gastroenterol Hepatol. 2021. PMID: 33338442 Clinical Trial.
Protecting scientific integrity in an age of generative AI.
Blau W, Cerf VG, Enriquez J, Francisco JS, Gasser U, Gray ML, Greaves M, Grosz BJ, Jamieson KH, Haug GH, Hennessy JL, Horvitz E, Kaiser DI, London AJ, Lovell-Badge R, McNutt MK, Minow M, Mitchell TM, Ness S, Parthasarathy S, Perlmutter S, Press WH, Wing JM, Witherell M. Blau W, et al. Proc Natl Acad Sci U S A. 2024 May 28;121(22):e2407886121. doi: 10.1073/pnas.2407886121. Epub 2024 May 21. Proc Natl Acad Sci U S A. 2024. PMID: 38771193 Free PMC article. No abstract available.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Baden D, Zukunft S, Hernandez G, Wolgast N, Steinhauser S, Pohlmann A, Schliemann C, Mikesch JH, Steffen B, Sauer T, Hanoun M, Schafer-Eckart K, Krause SW, Hanel M, Einsele H, Jost E, Brummendorf TH, Scholl S, Hochhaus A, Neubauer A, Burchert A, Kaufmann M, Niemann D, Schaich M, Blau W, Kiani A, Gorner M, Kaiser U, Kullmer J, Weber T, Berdel WE, Ehninger G, Muller-Tidow C, Platzbecker U, Serve H, Bornhauser M, Rollig C, Baldus CD, Fransecky L. Baden D, et al. Among authors: blau w. Haematologica. 2024 Aug 1;109(8):2469-2477. doi: 10.3324/haematol.2024.285225. Haematologica. 2024. PMID: 38654660 Free PMC article.
New strategies in GVHD prophylaxis.
Kiehl MG, Shipkova M, Basara N, Blau WI, Fauser AA. Kiehl MG, et al. Among authors: blau wi. Bone Marrow Transplant. 2000 May;25 Suppl 2:S16-9. doi: 10.1038/sj.bmt.1702346. Bone Marrow Transplant. 2000. PMID: 10933180
Carbon nanotube-based functional materials for optical limiting.
Chen Y, Lin Y, Liu Y, Doyle J, He N, Zhuang X, Bai J, Blau WJ. Chen Y, et al. Among authors: blau wj. J Nanosci Nanotechnol. 2007 Apr-May;7(4-5):1268-83. doi: 10.1166/jnn.2007.308. J Nanosci Nanotechnol. 2007. PMID: 17450890 Review.
117 results